<qa>  What is the STUDY TO EVALUATE?STUDY TO EVALUATE THE EFFICACY, SAFETY, TOLERABILITY, AND PHARMACOKINETICS OF MBX-2982 ADMINISTERED DAILY FOR 4 WEEKS AS MONOTHERAPY IN PATIENTS WITH TYPE 2 DIABETES: 